These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Destabilization of macrophage migration inhibitory factor by 4-IPP reduces NF-κB/P-TEFb complex-mediated c-Myb transcription to suppress osteosarcoma tumourigenesis. Zheng L; Feng Z; Tao S; Gao J; Lin Y; Wei X; Zheng B; Huang B; Zheng Z; Zhang X; Liu J; Shan Z; Chen Y; Chen J; Zhao F Clin Transl Med; 2022 Jan; 12(1):e652. PubMed ID: 35060345 [TBL] [Abstract][Full Text] [Related]
4. The tautomerase active site of macrophage migration inhibitory factor is a potential target for discovery of novel anti-inflammatory agents. Lubetsky JB; Dios A; Han J; Aljabari B; Ruzsicska B; Mitchell R; Lolis E; Al-Abed Y J Biol Chem; 2002 Jul; 277(28):24976-82. PubMed ID: 11997397 [TBL] [Abstract][Full Text] [Related]
5. Novel inhibitors of macrophage migration inhibitory factor prevent cytokine-induced beta cell death. Vujicic M; Nikolic I; Krajnovic T; Cheng KF; VanPatten S; He M; Stosic-Grujicic S; Stojanovic I; Al-Abed Y; Saksida T Eur J Pharmacol; 2014 Oct; 740():683-9. PubMed ID: 24967533 [TBL] [Abstract][Full Text] [Related]
6. Targeting distinct tautomerase sites of D-DT and MIF with a single molecule for inhibition of neutrophil lung recruitment. Rajasekaran D; Zierow S; Syed M; Bucala R; Bhandari V; Lolis EJ FASEB J; 2014 Nov; 28(11):4961-71. PubMed ID: 25016026 [TBL] [Abstract][Full Text] [Related]
7. Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer. Charan M; Das S; Mishra S; Chatterjee N; Varikuti S; Kaul K; Misri S; Ahirwar DK; Satoskar AR; Ganju RK Cell Death Dis; 2020 Sep; 11(9):774. PubMed ID: 32943608 [TBL] [Abstract][Full Text] [Related]
8. Macrophage migration inhibitory factor (MIF) tautomerase inhibitors as potential novel anti-inflammatory agents: current developments. Garai J; Lóránd T Curr Med Chem; 2009; 16(9):1091-114. PubMed ID: 19275614 [TBL] [Abstract][Full Text] [Related]
9. Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP suppresses osteoclast formation and promotes osteoblast differentiation through the inhibition of the NF-κB signaling pathway. Zheng L; Gao J; Jin K; Chen Z; Yu W; Zhu K; Huang W; Liu F; Mei L; Lou C; He D FASEB J; 2019 Jun; 33(6):7667-7683. PubMed ID: 30893559 [TBL] [Abstract][Full Text] [Related]
10. Macrophage migration inhibitory factor is regulated by HIF-1α and cAMP and promotes renal cyst cell proliferation in a macrophage-independent manner. Safi W; Kraus A; Grampp S; Schödel J; Buchholz B J Mol Med (Berl); 2020 Nov; 98(11):1547-1559. PubMed ID: 32885302 [TBL] [Abstract][Full Text] [Related]
11. Structural Plasticity in the C-Terminal Region of Macrophage Migration Inhibitory Factor-2 Is Associated with an Induced Fit Mechanism for a Selective Inhibitor. Pantouris G; Bucala R; Lolis EJ Biochemistry; 2018 Jul; 57(26):3599-3605. PubMed ID: 29847104 [TBL] [Abstract][Full Text] [Related]
12. Critical modifications of the ISO-1 scaffold improve its potent inhibition of macrophage migration inhibitory factor (MIF) tautomerase activity. Cheng KF; Al-Abed Y Bioorg Med Chem Lett; 2006 Jul; 16(13):3376-9. PubMed ID: 16682188 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological inhibition of MIF interferes with trophoblast cell migration and invasiveness. Jovanović Krivokuća M; Stefanoska I; Abu Rabi T; Al-Abed Y; Stošić-Grujičić S; Vićovac Lj Placenta; 2015 Feb; 36(2):150-9. PubMed ID: 25530499 [TBL] [Abstract][Full Text] [Related]
14. 4-IPP, a selective MIF inhibitor, causes mitotic catastrophe in thyroid carcinomas. Varinelli L; Caccia D; Volpi CC; Caccia C; De Bortoli M; Taverna E; Gualeni AV; Leoni V; Gloghini A; Manenti G; Bongarzone I Endocr Relat Cancer; 2015 Oct; 22(5):759-75. PubMed ID: 26206776 [TBL] [Abstract][Full Text] [Related]
15. Oral squamous carcinoma cells promote macrophage polarization in an MIF-dependent manner. Barbosa de Souza Rizzo M; Brasilino de Carvalho M; Kim EJ; Rendon BE; Noe JT; Darlene Wise A; Mitchell RA QJM; 2018 Nov; 111(11):769-778. PubMed ID: 30016493 [TBL] [Abstract][Full Text] [Related]
16. MIF inhibitor, ISO-1, attenuates human pancreatic cancer cell proliferation, migration and invasion in vitro, and suppresses xenograft tumour growth in vivo. Cheng B; Wang Q; Song Y; Liu Y; Liu Y; Yang S; Li D; Zhang Y; Zhu C Sci Rep; 2020 Apr; 10(1):6741. PubMed ID: 32317702 [TBL] [Abstract][Full Text] [Related]